WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , Scientific Journal Impact Factor (SJIF) , IFSIJ Measure of Journal Quality , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , Research Publication Rating and Indexing , Doi-Digital Online Identifier , ISSN National Centre , Zenodo Indexing , International CODEN Service, USA , 

ISSN 2457-0400

Impact Factor  :  7.675

WJAHR Citation

  All Since 2020
 Citation  105  60
 h-index  4  4
 i10-index  3  2

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • WJAHR: FEBRUARY ISSUE PUBLISHED

    FEBRUARY 2026 Issue has been successfully launched on FEBRUARY 2026.

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR February 2026 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased from  5.464 to 7.675 for Year 2026.

Best Article Awards

World Journal of Advance Healthcare Research (WJAHR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

GLOMERULAR DISEASE: IRAQI DATA 2020-2024

*Dr. Fatima Fawzi, Dr. Talib Al-Zaidi

ABSTRACT

Background: Glomerular diseases represent a diverse group of renal pathologies with significant morbidity. Understanding their demographic distribution is crucial for early diagnosis and effective management. Aim: To assess the prevalence and patterns of glomerular diseases in Iraq over a five-year period (2020–2024) with respect to age, sex, and temporal trends. Patients and Methods: A retrospective analysis was conducted on 1,377 patients who underwent renal biopsy and were diagnosed with various types of glomerular disease. Data were categorized and analyzed based on age, sex, and year of diagnosis. Histopathological patterns were classified according to standard diagnostic criteria. Results: Focal Segmental Glomerulosclerosis (FSGS) was the most common diagnosis (28.54%), followed by Membranous Glomerulonephritis (21.79%), Minimal Change Disease (16.63%), and IgA Nephropathy (16.34%). IgA Nephropathy showed a significant male predominance (p=0.009) and an increasing trend over time (p=0.088). Minimal Change Disease was more frequent in younger patients (p<0.001), while Membranous GN increased with age (p<0.001). Lupus Nephritis was significantly more common in females (p=0.001). A statistically significant rise was noted in C3 Glomerulopathy (p=0.006) and Pauci-immune GN (p=0.012) in recent years. Several diseases, such as MPGN and monoclonal-related nephropathies, showed strong age associations, and the "Other" category of diagnoses significantly declined over time (p=0.028), indicating improved diagnostic specificity. Conclusion: The spectrum of glomerular diseases in Iraq shows significant age- and sex-based variation, with emerging trends in immune-complex and complement-mediated nephropathies. These findings underscore the need for improved diagnostic infrastructure, national registry development, and tailored clinical strategies to address evolving disease patterns.

[Full Text Article] [Download Certificate]